Robert Bayer is a US researcher of lobster nutrition, management, and pathology.
Career
Since 2018, he is serving as the chief science officer at Lobster Unlimited, a company that is creating value-added products from lobster processing waste byproducts.[1][2] From 1995 to 2018, he served as the executive director of The Lobster Institute at the University of Maine,[3][1]
Bayer is an alumnus of the University of Vermont, where he received his bachelor's and master's degree, and Michigan State University, where he received his doctoral degree.[4] He is also a professor emeritus of Animal and Veterinary Sciences at the University of Maine.[1] He holds several research patents, including one for gaffkemia vaccine[5] and another one for the application of lobster hemolymph to treat mammalian tissue lesions.[4][6]